Who owns Design Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of DSGN from SEC Form 13F filings across 135 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 135 institutions disclosed 43.2M shares of Design Therapeutics, Inc. worth $625.2M — about 69.1% of shares outstanding; the largest disclosed holder is SR One Capital Management, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
135
13F holders
$625.2M
value, 2026 filers
69.1%
of shares outstanding (43.2M sh)
27
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of DSGN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | SR One Capital Management, LP | 6.5M | $94.4M | 9.1% | 10.4% | 0.0% |
| 2 | Logos Global Management LP | 3.0M | $43.4M | 1.9% | 4.8% | +53.8% |
| 3 | BAKER BROS. ADVISORS LP | 2.7M | $38.8M | 0.2% | 4.3% | +3.6% |
| 4 | Driehaus Capital Management LLC | 2.7M | $38.5M | 0.2% | 4.3% | +52.5% |
| 5 | BlackRock, Inc. | 2.7M | $38.5M | 0.0% | 4.3% | +24.7% |
| 6 | Point72 Asset Management, L.P. | 2.4M | $34.2M | 0.0% | 3.8% | -13.1% |
| 7 | Trails Edge Capital Partners, LP | 2.0M | $29.0M | 4.6% | 3.2% | +134.9% |
| 8 | Frazier Life Sciences Management, L.P.NEW | 1.8M | $26.2M | 0.6% | 2.9% | new |
| 9 | Vivo Capital, LLC | 1.6M | $23.3M | 2.1% | 2.6% | 0.0% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 1.6M | $22.7M | 0.0% | 2.5% | +16.4% |
| 11 | Caption Management, LLC | 1.1M | $16.2M | 0.1% | 1.8% | +1189.5% |
| 12 | Almitas Capital LLC | 1.0M | $14.9M | 3.6% | 1.6% | -32.9% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 958,417 | $13.9M | 0.0% | 1.5% | +38.4% |
| 14 | Sofinnova Investments, Inc.NEW | 865,135 | $12.5M | 0.6% | 1.4% | new |
| 15 | FMR LLC | 776,462 | $11.2M | 0.0% | 1.2% | -2.7% |
| 16 | MORGAN STANLEY | 765,425 | $11.1M | 0.0% | 1.2% | +16.6% |
| 17 | STATE STREET CORP | 736,221 | $10.7M | 0.0% | 1.2% | +11.6% |
| 18 | Woodline Partners LP | 700,354 | $10.1M | 0.0% | 1.1% | -27.2% |
| 19 | DIMENSIONAL FUND ADVISORS LP | 694,743 | $10.1M | 0.0% | 1.1% | +60.9% |
| 20 | GOLDMAN SACHS GROUP INC | 656,584 | $9.5M | 0.0% | 1.1% | +30.1% |
| 21 | JACOBS LEVY EQUITY MANAGEMENT, INC | 565,597 | $8.2M | 0.0% | 0.9% | +95.4% |
| 22 | ACADIAN ASSET MANAGEMENT LLC | 537,479 | $7.8M | 0.0% | 0.9% | -12.8% |
| 23 | Siren, L.L.C.NEW | 523,212 | $7.6M | 0.2% | 0.8% | new |
| 24 | Qube Research & Technologies Ltd | 437,079 | $6.3M | 0.0% | 0.7% | +1178.6% |
| 25 | RENAISSANCE TECHNOLOGIES LLC | 387,913 | $5.6M | 0.0% | 0.6% | -5.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.